2023
DOI: 10.1101/2023.02.15.528751
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Structural basis for lysophosphatidylserine recognition by GPR34

Abstract: GPR34 is a recently identified G-protein coupled receptor, which has an immunomodulatory role and recognizes lysophosphatidylserine (LysoPS) as a putative ligand. Here, we report cryo-electron microscopy structures of human GPR34-Gi complex bound with either the LysoPS analogue S3E-LysoPS, which contains an ethoxy group at the sn-1 position, or M1, a derivative of S3E-LysoPS in which oleic acid is substituted with a metabolically stable aromatic fatty acid surrogate. In both structures, the ligand-binding pock… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 62 publications
0
4
0
Order By: Relevance
“…The development of orally bioavailable GPR34 agonists with improved brain penetrance would enable more comprehensive investigations into the therapeutic potential of GPR34 activation in AD models. In this regard, our recent elucidation of the GPR34-M1 binding structure (19) may facilitate the rational design of novel GPR34 agonists. However, it is also important to consider potential side effects related to GPR34's roles in immune regulation and neuropathic pain (24).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The development of orally bioavailable GPR34 agonists with improved brain penetrance would enable more comprehensive investigations into the therapeutic potential of GPR34 activation in AD models. In this regard, our recent elucidation of the GPR34-M1 binding structure (19) may facilitate the rational design of novel GPR34 agonists. However, it is also important to consider potential side effects related to GPR34's roles in immune regulation and neuropathic pain (24).…”
Section: Discussionmentioning
confidence: 99%
“…Together with P2RY10 and GPR174, GPR34 comprises the lysophosphatidylserine (LysoPS) receptor family (14, 15). Uniquely within this receptor family, GPR34 exhibits selectivity for LysoPS species with a fatty acid at the sn -2 position (1619). While GPR34 is involved in various immunomodulatory functions (2022), another study highlights its importance in the regulation of phagocytosis in microglia (23).…”
Section: Introductionmentioning
confidence: 99%
“…In a preprint paper [ 43 ], the authors reported 2 cryo-EM structures of GPR34-Gi complex bound with the LysoPS analogue S3E-LysoPS or its derivate M1. S3E-LysoPS is a sn-3 LysoPS containing an ethoxy group at the sn-1 position, while what we used in our study is sn-1 LysoPS.…”
Section: Discussionmentioning
confidence: 99%
“…The single-chain variable fragment of mAb16 (scFv16), another remarkable antibody, specifically recognizes the interface between the N-terminal helix of Gαi (αN helix) and Gβ 10 . scFv16 also imparts resistance to GTPγS on the G protein and enhances the requisite features for cryo-EM structural analysis, thereby facilitating structural determination 1,2,[11][12][13][14] . Furthermore, the versatile applicability of scFv16 extends to other G-proteins through substitution with the αN helix of the Gα subunit.…”
Section: Introductionmentioning
confidence: 99%